M5A‐IL‐2 ICK displayed potent antitumor effects in CEA+ breast and colon cancers using an immunocompetent mouse model with human CEA transgene expression, including tumor eradication and induction of immune memory when combined with stereotactic radiation therapy (SRT).13 The gene discussed is IL2; the disease is neoplasm.